Our resources

Displaying 18 of 112 results

Sort by:

Search our resources for all activities and content produced by the Association and our members.

Restricted access

19 Jun 2026

T66 Costs associated with EG poisoning management could be significantly reduced by aligning discontinuation thresholds across clinical guidelines

LabMedUK26 - Posters

Restricted access

19 Jun 2026

T39 Measurement of Glial Fibrillary Acidic Protein and Ubiquitin Carboxyl-terminal Hydrolase L1 to test for the presence of CSF in fluid samples

LabMedUK26 - Posters

Restricted access

19 Jun 2026

W35 Accuracy of GFR estimation using creatinine and cystatin C for monitoring moderate CKD in adults: prospective, longitudinal data from the eGFR-C

LabMedUK26 - Posters

Restricted access

19 Jun 2026

W34Accuracy of glomerular filtration rate estimation using creatinine and cystatinC a prospective study in adults with moderate chronic kidney disease

LabMedUK26 - Posters

Restricted access

19 Jun 2026

T68 Retrospective case review series of EG analysis in two regional toxicology laboratories in the UK highlights recurrent presentation is common

LabMedUK26 - Posters

Restricted access

19 Jun 2026

W68 The development and validation of an LC-MS MS method.pdf

LabMedUK26 - Posters

Restricted access

18 Jun 2026

T65 Scoline can be used as an alternative to the inhibitor Ro-02-0683 to determine butyrylcholinesterase phenotype.pdf

LabMedUK26 - Posters

Restricted access

18 Jun 2026

T61 More Than Just a Cutoff Calibrator Challenges in a Urine THC Verification on the Abbott Alinity Platform.pdf

LabMedUK26 - Posters

Restricted access

18 Jun 2026

T59 Uncovering Synthetic Cannabinoids in Vape Fluids.pdf

LabMedUK26 - Posters

Restricted access

18 Jun 2026

T60 Validation of a synthetic cannabinoid receptor agonists (SCRA) assay by LC-HRMS.pdf

LabMedUK26 - Posters

Restricted access

18 Jun 2026

T58 Development of a High-Resolution Accurate Mass Spectrometry Method for detection of Novel Synthetic Opioids.pdf

LabMedUK26 - Posters

Restricted access

18 Jun 2026

T57 Development and Validation of a Method for the Measurement of the Anti-Seizure Medications.pdf

LabMedUK26 - Posters

Restricted access

18 Jun 2026

T40 Operational performance and turnaround time of CSF free kappa light chains in comparison with isoelectric focusing.pdf

LabMedUK26 - Posters

Restricted access

18 Jun 2026

M4 Are Kappa Free Light Chains and the Index a Reliable Alternative Biomarker to Oligoclonal Banding for Diagnosis of Multiple Sclerosis.pdf

LabMedUK26 - Posters

Restricted access

18 Jun 2026

W38 Clinical Impact of Paediatric AKI E Alerts in a UK Tertiary Centre A Retrospective Audit.pdf

LabMedUK26 - Posters

Restricted access

18 Jun 2026

W37 The AKI Alert how is it used in a large NHS trust A Nance pdf for mobile v2.pdf

LabMedUK26 - Posters

Restricted access

18 Jun 2026

W33 Audit of Conformance to Getting It Right First Time Acute Kidney Injury Recommendations for the Detection and Alerting of Results.pdf

LabMedUK26 - Posters

Restricted access

18 Jun 2026

W36 Implementation of reflex Kidney Failure Risk Equation (KFRE) reporting An audit of results and clinical impact.pdf

LabMedUK26 - Posters